The Wall Street Journal had an article last week examining the use of drugs in Silicon Valley. Here’s a key paragraph:
Routine drug use has moved from an after-hours activity squarely into corporate culture, leaving boards and business leaders to wrestle with their responsibilities for a workforce that frequently uses. Tech executives and employees see psychedelics and similar substances, including psilocybin, ketamine, and LSD, as gateways to business breakthroughs.
Why do we care?
I debated covering this.
Here’s why I think we care – at least in Silicon Valley, norms are shifting. Broader IT tends to move slower than that … but it can often trend that way. I’m not going to advocate either way. I will offer that business leaders should be aware of the trend and continue to track it. This may become a “thing” to know about.
